Trenor Cameron C. IIIinsider trades

In SEC Form 4 filings, Trenor Cameron C. III is listed as Chief Medical Officer of AN2 Therapeutics, Inc. (ANTX). Trenor Cameron C. III reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 16.

Companies and roles

Company	Role	Transactions	Last filed
ANTXAN2 Therapeutics, Inc.	Chief Medical Officer	2	Sep 16

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-16

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ANTXAN2 Therapeutics, Inc.	Sep 15	Sep 16	A	116,667	$0.00	$0	116,667	No	Form 4
ANTXAN2 Therapeutics, Inc.	Sep 15	Sep 16	A · derivative	233,333	$5.36	$1,250,665	233,333	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.